Merchavia Holdings and Investments Ltd. invests in med tech companies in Israel. The company develops diagnostic technology for the detection of cancer; wearable equipment, such as watches, bracelets, patches, etc. with wearable sensor technology for the medical diagnosis and monitoring; Aura smart air, a data-driven air quality management platform based on user behavior algorithm that detects indoor and outdoor air quality based on real-time monitoring through smart sensors; and TrainPain, a digital product to enhance mental and emotional well-being for people living with neuropathic and fibromyalgia pain. It also develops RevDx (Revolutionary Diagnostics), a hand-held device for on-the-spot complete blood count tests; a rechargeable electrical cannabis inhaler device with bluetooth connectivity to VEOLI App, which manages dosing and capsules supply; and an artificial intelligence-driven neuromonitoring tool for operating rooms to prevent nerve injury during surgery. In addition, the company engages in the development, manufacturing, and commercialization of women’s health products, which include Ballerine, a copper-based hormone-free intrauterine contraceptive; and a product that is in Phase IIa clinical study for the treatment of abnormal uterine bleeding with spherical endometrial ablation device. Further, the company engages in the medical distribution business. The company was formerly known as Nepco Star Ltd. and changed its name to Merchavia Holdings and Investments Ltd. in November 2014. Merchavia Holdings and Investments Ltd. was incorporated in 1972 and is headquartered in Bnei Brak, Israel.